Naghibi Khosrou, Kashefi Parviz, Abtahi Amir Mohamad
Department of Anesthesia and Intensive Care, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
J Res Med Sci. 2013 Jul;18(7):567-72.
In this randomized, double-blinded study, we investigated the preemptive effects of propofol, remifentanil or ketamine on post-operative pain scores and analgesic requirements in elective lower abdominal surgeries under general anesthesia during the first 24 h of post-operative period.
Seventy five patients, American Society of Anesthesiologists physical status I or II candidate for elective lower abdominal surgery under general anesthesia were randomized to three groups (25 each). According to their allocated group, patients received either propofol 0.25 mg/kg, remifentanil 0.25 mic/kg or ketamine 0.3 mg/kg as preemptive analgesia immediately after the induction of general anesthesia. Post-operative pain scores with a numerical rating scale (visual analogue scale 0-10) were assessed and analgesic requirements and side-effects were compared through analysis using the SPSS version 18 in the post-operative period; post-anesthesia care unit 2, 6, 12 and 24 h.
Patients' demographics were similar in all groups. The pain scores were significantly lower in remifentanil group immediately after recovery and also at 2 and 6 h post-operatively, but it reversed at 12 and 24 h after recovery comparing with propofol and ketamine. However, the mean of administered morphine in the first 24 h was significantly lower in propofol group (18.97 ± 6.6) comparing with remifentanil group (21.96 ± 6.55) and ketamine group (24.26 ± 5.84) (P value, 0.01).
Prophylactic preemptive single dose of intravenous (IV) 0.25 mg/kg propofol significantly decreased post-operative analgesia requirements comparing with IV 0.3 mg/kg ketamine or 0.25 μg/kg remifentanil.
在这项随机双盲研究中,我们调查了丙泊酚、瑞芬太尼或氯胺酮对全身麻醉下择期下腹部手术术后24小时内术后疼痛评分和镇痛需求的超前镇痛效果。
75例美国麻醉医师协会身体状况为I或II级、拟行全身麻醉下择期下腹部手术的患者被随机分为三组(每组25例)。根据分组情况,患者在全身麻醉诱导后立即接受丙泊酚0.25mg/kg、瑞芬太尼0.25μg/kg或氯胺酮0.3mg/kg作为超前镇痛。采用数字评分量表(视觉模拟量表0 - 10)评估术后疼痛评分,并在术后麻醉恢复室2、6、12和24小时使用SPSS 18版软件分析比较镇痛需求和副作用。
所有组患者的人口统计学特征相似。瑞芬太尼组在苏醒后即刻以及术后2小时和6小时的疼痛评分显著低于其他组,但在苏醒后12小时和24小时与丙泊酚组和氯胺酮组相比出现逆转。然而,丙泊酚组术后24小时内吗啡的平均用量(18.97±6.6)显著低于瑞芬太尼组(21.96±6.55)和氯胺酮组(24.26±5.84)(P值,0.01)。
与静脉注射0.3mg/kg氯胺酮或0.25μg/kg瑞芬太尼相比,预防性单次静脉注射0.25mg/kg丙泊酚可显著降低术后镇痛需求。